Avalo Therapeutics, Inc. (AVTX)
NASDAQ·Healthcare·Biotechnology
$15.17
+5.83%
Mkt Cap $147.95M
Analyst Ratings
Buy
10
Hold
0
Sell
0
Price Target (11 analysts)
$47.14
Range $34.00 – $60.00
Implied Upside
+210.8%
Consensus $47.14 vs current $15.17
NASDAQ·Healthcare·Biotechnology
$15.17
+5.83%
Mkt Cap $147.95M
Buy
10
Hold
0
Sell
0
Price Target (11 analysts)
$47.14
Range $34.00 – $60.00
+210.8%
Consensus $47.14 vs current $15.17